Skip to main content
OpenTrials

Clinical trial condition

Autoimmune Diseases of the Nervous System

Explore clinical trials studying Autoimmune Diseases of the Nervous System. Study availability and eligibility vary by location and protocol.

3,227 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Autoimmune Diseases of the Nervous System trial results

Completed

A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

NCT06637072

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Neurology Associates PA Maitland, Florida, United States
  • Visionary Investigators Network Miami, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details
Completed

Computerized Cognitive Training in MS

NCT03737825

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cognition Disorders, +9 more
Locations
  • Weill Institute for Neurosciences, University of California, San Francisco San Francisco, California, United States
  • Lausanne University Hospital (CHUV) Lausanne, Switzerland
View Trial Details
Completed

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

NCT06130540

Conditions
Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +18 more
Locations
  • Rheumatology Associates of South Florida Boca Raton, Florida, United States
  • FL Medical Clinic Orlando Health Zephyrhills, Florida, United States
  • Willow Rheumatology Wellness Willowbrook, Illinois, United States
  • Altoona Center for Clin Res Duncansville, Pennsylvania, United States
View all 19 locations
View Trial Details
Completed

ETNA-MS Device Validation Study

NCT06256731

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • MS Integrated Center Phoenix, Arizona, United States
  • Michigan Institute for Neurological Disorders Farmington Hills, Michigan, United States
  • Memorial Healthcare Owosso, Michigan, United States
  • Premier Neurology Research, P.C. Greenville, South Carolina, United States
View Trial Details
Completed

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

NCT04930094

Conditions
Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • IRIS Research and Development Plantation, Florida, United States
  • Sarasota Arthritis Res Ctr Sarasota, Florida, United States
  • Novartis Investigative Site Iowa City, Iowa, United States
View all 104 locations
View Trial Details

Related conditions